CEO Monthly Issue 11 2018

16 CEO MONTHLY / ISSUE 11 2018 , Oct18321 TheClinigenGroup is a trustedglobal leader in the pharmaceutical industry, withoffices throughout theworld. InOctober, thefirm’s Chief ExecutiveOfficer, ShaunChilton, was recognised amongCEOMonthly’s 2018 LeadershipExcellenceAwards programme.We spoke to Shaun tofindout howhehas driven this unique, pace-setting business. Helping to Resolve a Global Healthcare Deficiency The world is now more connected than it has ever been. Technology has been the great unifier, allowing businesses to interact with clients and customers to a degree that has previously been considered unimaginable. Today’s digital age is one that can be defined by this connectivity, however, not all sectors enjoy such a free flow of information or services. Clinigen’s mission statement is almost deceptively simple, “to deliver the right medicine to the right patient at the right time” – an easy task, you would think, in today’s climate. But, as Shaun is quick to correct, a substantial number of the world’s population has little or even no access to the right medication. This is the gap that Clinigen hopes to close - the challenge it is looking to resolve and overcome. Shaun starts the interview by offering a brief overview of Clinigen’s operations: “Clinigen operates as three synergistic businesses, operating in three areas of medicine access; Clinical Services, Unlicensed Medicines and Commercial Medicines. We aim to expand and extend the lifecycle of a medicine – whether we own the medicine ourselves or we work as a strategic partner with the owner of the medicine.” “We work in partnership with pharmaceutical and biotechnology companies around the world and provide a valuable service to hospital physicians and pharmacists in helping them access difficult to find medicines. We have a number of ways we interact with these clients and customers, on-and offline.” In just eight years, Clinigen have helped to revitalise a global healthcare deficiency, tackling a very real-world problem with a practical, comprehensive and robust solution. They work tirelessly to ensure that a healthcare professional can ethically access critically important medicines for those patients that need it most. With this in mind, it is difficult to overstate the importance of Clinigen’s work in their sector. Shaun takes a moment to emphasise the key elements to their success: “Clinigen has identified some long-term trends in the pharmaceutical industry that present unmet and underserved needs, which Clinigen has established a global expertise and infrastructure to provide solutions for. However, ultimately, the reason why Clinigen is successful is due to the quality, commitment and expertise of our people.” Shaun continues, commenting further on his team’s role: “They are why the business exists. They are its heartbeat – fundamental to its success. It is an absolute pleasure being the CEO of a company with a real purpose and where I work with such a talented and committed group of people.” The conversation soon turns to the specific challenges that Clinigen are facing, and how they aim to overcome them in the coming months. “We’ve grown very quickly and so we face the same challenge any other company in similar circumstances – how to make sure that we embrace the opportunities but continue to focus on providing products and services of the highest quality standards. Brexit and serialisation throw up some interesting challenges but as a global company these challenges of themselves are only unusual due to their scale and timing together and we have taken steps to make sure we have a variety of solutions and take advantage of the opportunities they also present.” This plays directly into Shaun’s plan to capitalise on Clinigen’s position to become the global leader in their field: “Our plans for 2019 hinge on the pursuit of our vision of becoming the ‘Trusted Global Leader in Access to Medicines’ and continues to get closer to our clients and customers to better understand how we can help them.” Clinigen’s future looks incredibly promising on the back of a number of high profile mergers and acquisitions. They are, above all, disruptors in a niche field, working tirelessly and diligently to drive the development of healthcare in the regions, and communities, that need it most. Contact: Shaun Chilton Address: Pitcairn House, Crown Square, First Ave, Burton on Trent, DE14 2WW, United Kingdom Website: www.clinigengroup.com Telephone: +44 (0) 1283 495 010